Drug Profile


Alternative Names: Adaprolol maleate; CDDD 2803; CTD 90107; HGP 2; IDR 90107

Latest Information Update: 23 May 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Xenon Vision
  • Class Antiglaucomas; Phenylacetates
  • Mechanism of Action Beta-adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Glaucoma

Most Recent Events

  • 23 May 2003 Discontinued - Phase-II for Glaucoma in USA (Ophthalmic)
  • 09 Sep 2002 No development reported - Phase-II for Glaucoma in USA (Ophthalmic)
  • 02 Oct 2000 This ophthalmic formulation of adaprolol is available for licensing from Corporate Technology Development Inc. (
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top